Optiver Holding
HUMA icon

Optiver Holding’s Humacyte HUMA Stock Holding History

Optiver Holding’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$733 Buy
939
+208
+28% +$193 ﹤0.01% 2539
2026
Q1 		$443 Sell
731
-98
-12% -$102 ﹤0.01% 2176
2025
Q4 		$796 Sell
829
-109
-12% -$154 ﹤0.01% 2240
2025
Q3 		$1.63K Buy
+938
New +$1.84K ﹤0.01% 2431

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Optiver Holding's HUMA Position: Q2 2026 in Review

Optiver Holding increased its Humacyte (HUMA) stake by 28% in Q2 2026, buying an estimated $193 and bringing the position to 939 shares worth $733. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Optiver Holding first reported a position in HUMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.63K in Q3 2025. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Optiver Holding held 939 shares of Humacyte worth $733 as of Q2 2026.
  • Optiver Holding bought 208 Humacyte shares in Q2 2026, an estimated $193.
  • Humacyte made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2539 holding.
  • Optiver Holding first reported a position in Humacyte in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Humacyte position peaked at $1.63K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.